3.19 USD
↗ 0.07 (2.24%)LIVE (AS OF 12:45 PM EDT)
NSRX is currently priced at $3.19. The technical outlook is "Strong Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 22, 2026.
Open?$3.11
High?$3.22
Low?$3.04
Prev. Close?$3.12
Volume?7.2K
Avg. Volume?N/A
VWAP?$3.13
Bid / Ask
Bid?$3.18 × 700
Ask?$3.24 × 2.5K
Spread?$0.06
Midpoint?$3.21
Valuation & Ratios
Market Cap?36.0M
Shares Out?11.7M
Float?6.4M
Float %?55.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.68%Low
Short Interest?172.5K
Days to Cover?3.1
Free Float6.4M
Avg Daily Volume55.7K
Settlement Date2026-05-29